Validation of the Korean version of the 16-Item Prodromal Questionnaire in a Non-Help-Seeking College Population

다국어 초록 (Multilingual Abstract)

Objective-To examine the reliability and validity of the Korean version of the 16-item Prodromal Questionnaire (KPQ-16) in nonhelp-seeking university students.

Methods-aAmong 2,246 university students participated in the initial screening, 257 subjects with KPQ-16 scores ≥4 were interviewed.The criteria for ultra-high risk (UHR) of psychosis of the Comprehensive Assessment of At-Risk Mental States (CAARMS) were the gold standard for diagnosis. An exploratory modified version of the questionnaire (mKPQ-16), to which three items from the Eppendorf Schizophrenia Inventory were added, was also used to compensate for items on thought and cognitive problems.

Result-Seventeen subjects met the CAARMS criteria for UHR of psychosis. The area under the receiver operating characteristic curve (AUROC) was highest for the mKPQ-16 total score (AUROC=0.831, p<0.001). The use of cutoff total scores of 7 for the mKPQ- 16 and 6 for the KPQ-16 resulted in the best balance of sensitivity (76.5% and 64.7%, respectively) and specificity (75.4% and 71.2%, respectively).

Conclusion-The Korean versions of the PQ-16 are good instruments for screening for psychosis risk in university students. This validation of a questionnaire version with a small number of items may make it feasible to screen large numbers of young adults in the community.

목차 (Table of Contents)

• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• ACKNOWLEDGEMENTS
• REFERENCES

참고문헌 (Reference)

1 McGorry P, "Why We need a transdiagnostic staging approach to emerging psychopathology, early diagnosis, and treatment" 73 : 191-192, 2016

2 Han C, "Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study" 49 : 218-223, 2008

3 Chung YC, "Validation of the Korean version of the Eppendorf Schizophrenia Inventory as a screening measure to detect adolescents at ultra-high risk for psychosis" 7 : 71-79, 2013

4 Owoso A, "Validation of a modified version of the PRIME screen for psychosis-risk symptoms in a non-clinical Kenyan youth sample" 55 : 380-387, 2014

5 Spitzer RL, "Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire" 282 : 1737-1744, 1999

6 Fusar-Poli P, "Towards a standard psychometric diagnostic interview for subjects at ultra high risk of psychosis: CAARMS versus SIPS" 2016 : 7146341-, 2016

7 Ising HK, "The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population" 38 : 1288-1296, 2012

8 Loewy RL, "The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes" 79 : 117-125, 2005

9 McGorry PD, "The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey" 92 : 241-249, 1995

10 Muller M, "The Self-screen-Prodrome as a short screening tool for pre-psychotic states" 123 : 217-224, 2010

11 Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10" 59 (59): 22-33, 1998

12 Yang LH, "Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis" 168 : 9-15, 2015

13 Loewy RL, "Self-report of attenuated psychotic experiences in a college population" 93 : 144-151, 2007

14 Addington J, "Screening tools for clinical high risk for psychosis" 9 : 345-356, 2015

15 O'Toole BI, "Screening for low prevalence disorders" 34 (34): S39-S46, 2000

16 Kim SW, "Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis" 158 : 39-44, 2014

17 Kim SW, "Relationship between erythrocyte fatty acid composition and psychopathology in the vienna omega-3 study" 11 : e0151417-, 2016

18 Loewy RL, "Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B)" 129 : 42-46, 2011

19 Loewy RL, "Prodromal psychosis screening in adolescent psychiatry clinics" 6 : 69-75, 2012

20 Miller TJ, "Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability" 29 : 703-715, 2003

21 Post SG, "Preventing schizophrenia and Alzheimer disease: comparative ethics" 51 : 103-108, 2001

22 Amminger GP, "Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids" 5 : e495-, 2015

23 Yung AR, "Monitoring and care of young people at incipient risk of psychosis" 22 : 283-303, 1996

24 Yung AR, "Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states" 39 : 964-971, 2005

25 Nelson B, "Long-term follow-up of a group at ultra high risk (prodromal) for psychosis: the PACE 400 study" 70 : 793-802, 2013

26 Mass R, "Introducing the Eppendorf Schizophrenia Inventory (ESI) as a psychometric method for schizotypy research" 42 : 525-534, 2007

27 Escher S, "Independent course of childhood auditory hallucinations: a sequential 3-year follow-up study" 43 : s10-s18, 2002

28 Schimmelmann BG, "Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort" 42 : 982-990, 2008

29 김성완, "Effects of Group Cognitive-Behavioral Therapy in Young Patients in the Early Stage of Psychosis" 대한신경정신의학회 14 (14): 609-617, 2017

30 McGorry PD, "Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages" 187 (187): S8-S10, 2007

31 Addington J, "Duration of untreated psychosis in community treatment settings in the United States" 66 : 753-756, 2015

32 American Psychiatric-Association, "Diagnostic and Statistical Manual of Mental Disorder. 5th Ed." American Psychiatric Publishing 2013

33 김성완, "Design and Methodology of the Korean Early Psychosis Cohort Study" 대한신경정신의학회 14 (14): 93-99, 2017

34 Kane JM, "Comprehensive versus usual community care for firstepisode psychosis: 2-year outcomes from the NIMH RAISE early treatment program" 173 : 362-372, 2016

35 Hutton P, "Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis" 44 : 449-468, 2014

36 Fonseca-Pedrero E, "Assessing self-reported clinical high risk symptoms in community-derived adolescents: a psychometric evaluation of the Prodromal Questionnaire-Brief" 66 : 201-208, 2016

37 Kim SW, "Are current labeling terms suitable for people who are at risk of psychosis?" 188 : 172-177, 2017

38 Schimmelmann BG, "Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies" 14 : 189-197, 2015

39 Yoo J, "A study of duration of untreated psychosis (DUP) for first episode psychosis" 2 : 12-16, 2011

40 Kobayashi H, "A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population" 106 : 356-362, 2008